Charles Schwab
MJN

Charles Schwab’s Mead Johnson Nutrition Company MJN Stock Holding History

Charles Schwab’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-582,233
Closed -$51.9M – 3187
2017
Q1 		$51.9M Buy
582,233
+38,045
+7% +$3.13M 0.05% 352
2016
Q4 		$38.5M Buy
544,188
+20,191
+4% +$1.5M 0.04% 417
2016
Q3 		$41.4M Buy
523,997
+9,470
+2% +$808K 0.05% 370
2016
Q2 		$46.7M Buy
514,527
+6,927
+1% +$587K 0.06% 326
2016
Q1 		$43.1M Sell
507,600
-10,407
-2% -$774K 0.06% 327
2015
Q4 		$40.9M Buy
518,007
+13,854
+3% +$1.09M 0.06% 330
2015
Q3 		$35.5M Buy
504,153
+13,984
+3% +$1.15M 0.05% 340
2015
Q2 		$44.2M Buy
490,169
+9,353
+2% +$902K 0.06% 307
2015
Q1 		$48.3M Buy
480,816
+22,561
+5% +$2.28M 0.07% 285
2014
Q4 		$46.1M Buy
458,255
+18,390
+4% +$1.83M 0.07% 278
2014
Q3 		$42.3M Buy
439,865
+8,217
+2% +$779K 0.07% 263
2014
Q2 		$40.2M Buy
431,648
+6,032
+1% +$527K 0.07% 272
2014
Q1 		$35.4M Buy
425,616
+10,410
+3% +$844K 0.06% 291
2013
Q4 		$34.8M Buy
415,206
+11,832
+3% +$963K 0.07% 278
2013
Q3 		$29.9M Buy
403,374
+25,220
+7% +$1.89M 0.06% 303
2013
Q2 		$30M Buy
+378,154
New +$30.3M 0.07% 281

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Charles Schwab's MJN Position: Q2 2017 in Review

Charles Schwab sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 582,233 shares — an estimated $51.9M sold.

Charles Schwab first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $51.9M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Charles Schwab reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Charles Schwab sold 582,233 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $51.9M.
  • Charles Schwab first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Charles Schwab's Mead Johnson Nutrition Company position peaked at $51.9M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.